secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-06-23T00:22:28+00:00
Accession:  0001193125-26-278068
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics shareholders approve stock issuance for warrant exercises
------------------------------------------------------------------------------

- Proposal 1 passed: 9,090,763 votes for issuance of up to 925,927 shares from Series A and B warrants (March 2026 private placement).
- Proposal 2 passed: 9,091,165 votes for issuance of up to 2,344,828 shares from Common Warrants (November 2025 inducement).
- Both proposals had ~9.09M for, ~398k against, ~18k abstentions at the June 18, 2026 special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526278068/0001193125-26-278068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526278068/d158247d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-278068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer